Background Prostate cancer (PCa) has a profoundly immunosuppressive microenvironment
and is commonly immune excluded with few infiltrative lymphocytes and low levels of …

There are numerous transcriptional, proteomic and functional differences between monocyte-derived
dendritic cells (Mo-DC) and primary blood dendritic cells (BDC). The CMRF-56 …

Background Cancer testis antigens (CTAs) have gained interest in the field of anti-cancer
therapy as they offer the opportunity to target tumor cells with little off/on-target side effects …

Background Agonistic antibodies targeting CD137 in clinic have failed due to severe
hepatotoxicity, leading to the development of bispecific approaches that must rely on high tumor-…

Purpose: Patients with malignant pleural mesothelioma, a rapidly progressing malignancy
with a median survival time of 6 to 9 months, have previously responded poorly to …

Background Radiotherapy impacts the local immune response to cancers. Prostate Stereotactic
Body Radiotherapy (SBRT) is a highly focused method to deliver radiotherapy often …

… Nicolas van Kooten-Losio assisted with experimental design and execution, and technical …
Bryant, Dr Jen Hsu, (future doctor) Nick van Kooten-Losio, Dr Ben Kong, Fiona Kupresanin, Dr …

Dendritic- cells (DCs) have received considerable attention as potential targets for the
development of anticancer vaccines. DC-based anticancer vaccination relies on patient-derived …

Dendritic cell (DC)-based vaccines against cancer have been extensively developed over
the past two decades. Typically DC-based cancer immunotherapy entails loading patient-…